![Treatment with levodopa/carbidopa intestinal gel of advanced Parkinson's disease patients: Bulgarian experience - MDS Abstracts Treatment with levodopa/carbidopa intestinal gel of advanced Parkinson's disease patients: Bulgarian experience - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2018/08/0120_0189_000208_Table%201.png)
Treatment with levodopa/carbidopa intestinal gel of advanced Parkinson's disease patients: Bulgarian experience - MDS Abstracts
![Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease | npj Parkinson's Disease Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-021-00246-y/MediaObjects/41531_2021_246_Fig1_HTML.png)
Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease | npj Parkinson's Disease
![Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study - Parkinson's London Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study - Parkinson's London](https://parkinsons-london.co.uk/wp-content/uploads/2023/02/549999.png)
Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study - Parkinson's London
![Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients | Scientific Reports Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-024-54299-z/MediaObjects/41598_2024_54299_Fig1_HTML.png)
Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients | Scientific Reports
![Outcome Profiles in Advanced Parkinson's Disease Patients Treated With Long-Term Levodopa-Carbidopa Intestinal Gel in a Routine Clinical Practice: Analysis From the COSMOS Study - MDS Abstracts Outcome Profiles in Advanced Parkinson's Disease Patients Treated With Long-Term Levodopa-Carbidopa Intestinal Gel in a Routine Clinical Practice: Analysis From the COSMOS Study - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2020/09/0417_0603_000280_001.jpg)
Outcome Profiles in Advanced Parkinson's Disease Patients Treated With Long-Term Levodopa-Carbidopa Intestinal Gel in a Routine Clinical Practice: Analysis From the COSMOS Study - MDS Abstracts
![Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpjparkd.2016.23/MediaObjects/41531_2016_Article_BFnpjparkd201623_Fig1_HTML.jpg)
Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease
![JPM | Free Full-Text | Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments JPM | Free Full-Text | Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments](https://www.mdpi.com/jpm/jpm-11-00650/article_deploy/html/images/jpm-11-00650-g003.png)
JPM | Free Full-Text | Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments
![The levodopa-carbidopa intestinal gel (LCIG) system. PEG percutaneous... | Download Scientific Diagram The levodopa-carbidopa intestinal gel (LCIG) system. PEG percutaneous... | Download Scientific Diagram](https://www.researchgate.net/publication/334266588/figure/fig1/AS:777479371374592@1562376935153/The-levodopa-carbidopa-intestinal-gel-LCIG-system-PEG-percutaneous-endoscopic.png)
The levodopa-carbidopa intestinal gel (LCIG) system. PEG percutaneous... | Download Scientific Diagram
![Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence? | Semantic Scholar Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fbc01c72c624caef5d2095bbc2bcb7bea1e87efe/7-Table3-1.png)
Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence? | Semantic Scholar
![The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | Advances in Therapy The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | Advances in Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12325-021-01747-1/MediaObjects/12325_2021_1747_Figa_HTML.png)
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | Advances in Therapy
![JPM | Free Full-Text | Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors JPM | Free Full-Text | Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors](https://www.mdpi.com/jpm/jpm-11-00680/article_deploy/html/images/jpm-11-00680-g005.png)